Gastric cancer: adding glycosylation to the equation.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Trends in Molecular Medicine

• Publication date

  2013-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.molmed.2013.07.003PMID 23932995
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glycoproteomic analysis of serum from patients with gastric precancerous lesions.

  2013cited by this paper
• Somatic mutations and deletions of the E-cadherin gene predict poor survival of patients with gastric cancer.

  2013cited by this paper
• Expression of ST3GAL4 Leads to SLex Expression and Induces c-Met Activation and an Invasive Phenotype in Gastric Carcinoma Cells

  2013cited by this paper
• E-cadherin and adherens-junctions stability in gastric carcinoma: functional implications of glycosyltransferases involving N-glycan branching biosynthesis, N-acetylglucosaminyltransferases III and V.

  2013cited by this paper
• Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED)

  2013cited by this paper
• Aberrantly glycosylated MUC1 is expressed on the surface of breast cancer cells and a target for antibody-dependent cell-mediated cytotoxicity

  2013cited by this paper
• First‐degree relatives of patients with early‐onset gastric carcinoma show even at young ages a high prevalence of advanced OLGA/OLGIM stages and dysplasia

  2012cited by this paper
• Epithelial E- and P-cadherins: role and clinical significance in cancer.

  2012cited by this paper
• Essential role of gastric gland mucin in preventing gastric cancer in mice.

  2012cited by this paper
• Advances in membrane proteomics and cancer biomarker discovery: Current status and future perspective

  2012cited by this paper
• Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED)

  2012cited by this paper
• Lack of microRNA‐101 causes E‐cadherin functional deregulation through EZH2 up‐regulation in intestinal gastric cancer

  2012cited by this paper
• Loss and Recovery of Mgat3 and GnT-III Mediated E-cadherin N-glycosylation Is a Mechanism Involved in Epithelial-Mesenchymal-Epithelial Transitions

  2012cited by this paper
• Multiple post-translational modifications regulate E-cadherin transport during apoptosis

  2012cited by this paper
• Almost all human gastric mucin O-glycans harbor blood group A, B or H antigens and are potential binding sites for Helicobacter pylori.

  2012cited by this paper
• Roles of N-Acetylglucosaminyltransferase III in Epithelial-to-Mesenchymal Transition Induced by Transforming Growth Factor β1 (TGF-β1) in Epithelial Cell Lines*

  2012cited by this paper
• p120-catenin binding masks an endocytic signal conserved in classical cadherins

  2012cited by this paper
• α1‐3/4 fucosylation at Asn 241 of β‐haptoglobin is a novel marker for colon cancer: A combinatorial approach for development of glycan biomarkers

  2012cited by this paper
• Potential roles of N-glycosylation in cell adhesion

  2012cited by this paper
• Redefinition of the Carbohydrate Binding Specificity of Helicobacter pylori BabA Adhesin

  2012cited by this paper
• Development of an antibody-lectin enzyme immunoassay for fucosylated α-fetoprotein.

  2012cited by this paper
• Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): a new autosomal dominant syndrome

  2011cited by this paper
• ADP-Ribosylation Factor 6 Mediates E-Cadherin Recovery by Chemical Chaperones

  2011cited by this paper
• Roles of N-acetylglucosaminyltransferase III in Epithelial-to-mesenchymal Transition Induced by TGF-β1

  2011cited by this paper
• Branched N-glycans and their implications for cell adhesion, signaling and clinical applications for cancer biomarkers and in therapeutics.

  2011cited by this paper
• Epithelial cell polarity: a major gatekeeper against cancer?

  2011cited by this paper
• Enhanced Epithelial-Mesenchymal Transition-like Phenotype in N-Acetylglucosaminyltransferase V Transgenic Mouse Skin Promotes Wound Healing*

  2011cited by this paper
• Modulation of E-cadherin function and dysfunction by N-glycosylation

  2011cited by this paper
• ST6GalNAc-I controls expression of sialyl-Tn antigen in gastrointestinal tissues.

  2011cited by this paper
• Global cancer statistics

  2011cited by this paper
• Age-specific trends in incidence of noncardia gastric cancer in US adults.

  2010cited by this paper
• Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

  2010cited by this paper
• MUC1 immunotherapy.

  2010cited by this paper
• Neighborly relations: cadherins and mechanotransduction

  2010cited by this paper
• Hypoglycosylated E-cadherin promotes the assembly of tight junctions through the recruitment of PP2A to adherens junctions.

  2010cited by this paper
• Identification of fucosylated haptoglobin as a novel tumor marker for pancreatic cancer and its possible application for a clinical diagnostic test.

  2010cited by this paper
• Alterations in glycosylation as biomarkers for cancer detection

  2010cited by this paper
• Molecular Imaging of N-linked Glycosylation Suggests Glycan Biosynthesis Is a Novel Target for Cancer Therapy

  2010cited by this paper
• Glycan changes: cancer metastasis and anti-cancer vaccines

  2010cited by this paper
• MUC2 mucin is a major carrier of the cancer-associated sialyl-Tn antigen in intestinal metaplasia and gastric carcinomas.

  2010cited by this paper
• Germline CDH1 deletions in hereditary diffuse gastric cancer families

  2009cited by this paper
• Glycosylation Changes in Cancer -- Essentials of Glycobiology

  2009cited by this paper
• The second golden age of glycomics: from functional glycomics to clinical applications.

  2009cited by this paper
• Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression.

  2009cited by this paper
• Role of E-cadherin N-glycosylation profile in a mammary tumor model.

  2009cited by this paper
• N-Glycosylation of the I-like Domain of β1 Integrin Is Essential for β1 Integrin Expression and Biological Function

  2009cited by this paper
• Remodeling of the adherens junctions during morphogenesis.

  2009cited by this paper
• A mutual regulation between cell-cell adhesion and N-glycosylation: implication of the bisecting GlcNAc for biological functions.

  2009cited by this paper
• The role of N-acetylglucosaminyltransferase III and V in the post-transcriptional modifications of E-cadherin.

  2009cited by this paper
• The prospects of glycan biomarkers for the diagnosis of diseases.

  2009cited by this paper
• Immunotherapy for cancer: synthetic carbohydrate-based vaccines.

  2009cited by this paper
• Polarity proteins regulate mammalian cell-cell junctions and cancer pathogenesis.

  2009cited by this paper
• N-glycosylation status of E-cadherin controls cytoskeletal dynamics through the organization of distinct β-catenin- and γ-catenin-containing AJs.

  2009cited by this paper
• Regulation of Homotypic Cell-Cell Adhesion by Branched N-Glycosylation of N-cadherin Extracellular EC2 and EC3 Domains*

  2009cited by this paper
• Fut2-null mice display an altered glycosylation profile and impaired BabA-mediated Helicobacter pylori adhesion to gastric mucosa.

  2009cited by this paper
• Sialyl-Tn vaccine induces antibody-mediated tumour protection in a relevant murine model

  2009cited by this paper
• An N-Glycosylation Site on theβ-Propeller Domain of the Integrin α5 Subunit Plays Key Roles in Both Its Function and Site-specific Modification byβ1,4-N-Acetylglucosaminyltransferase III*

  2009cited by this paper
• MUC1 Limits Helicobacter pylori Infection both by Steric Hindrance and by Acting as a Releasable Decoy

  2009cited by this paper
• Nature meets nurture: molecular genetics of gastric cancer

  2009cited by this paper
• Hereditary gastric cancer.

  2009cited by this paper
• Human disease glycomics/proteome initiative (HGPI).

  2008cited by this paper
• Unglycosylation at Asn-633 made extracellular domain of E-cadherin folded incorrectly and arrested in endoplasmic reticulum, then sequentially degraded by ERAD

  2008cited by this paper
• Cell adhesion receptors in mechanotransduction.

  2008cited by this paper
• N-glycosylation at Asn residues 554 and 566 of E-cadherin affects cell cycle progression through extracellular signal-regulated protein kinase signaling pathway.

  2008cited by this paper
• Inverse Correlation between the Extent of N-Glycan Branching and Intercellular Adhesion in Epithelia

  2008cited by this paper
• The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1

  2008cited by this paper
• Inhibition of the sodium/potassium ATPase impairs N-glycan expression and function.

  2008cited by this paper
• Mechanisms and sequelae of E‐cadherin silencing in hereditary diffuse gastric cancer

  2008cited by this paper
• The cell-cell adhesion molecule E-cadherin

  2008cited by this paper
• The Implication of N-Acetylglucosaminyl- transferase V Expression in Gastric Cancer

  2008cited by this paper
• Frontiers in glycomics: Bioinformatics and biomarkers in disease An NIH White Paper prepared from discussions by the focus groups at a workshop on the NIH campus, Bethesda MD (September 11–13, 2006)

  2008cited by this paper
• Potential of N-glycan in cell adhesion and migration as either a positive or negative regulator

  2008cited by this paper
• Helicobacter pylori induces beta3GnT5 in human gastric cell lines, modulating expression of the SabA ligand sialyl-Lewis x.

  2008cited by this paper
• Infection by Helicobacter pylori expressing the BabA adhesin is influenced by the secretor phenotype

  2008cited by this paper
• Inverse correlation between the extent of N-glycan branching and intercellular adhesion in epithelia. Contribution of the Na,K-ATPase beta1 subunit.

  2008cited by this paper
• Biological significance of cancer-associated sialyl-Tn antigen: modulation of malignant phenotype in gastric carcinoma cells.

  2007cited by this paper
• Feasibility and cost‐effectiveness of using magnification chromoendoscopy and pepsinogen serum levels for the follow‐up of patients with atrophic chronic gastritis and intestinal metaplasia

  2007cited by this paper
• Biosynthesis and expression of the Sda and sialyl Lewis x antigens in normal and cancer colon.

  2007cited by this paper
• Inhibition of the growth of human gastric carcinoma in vivo and in vitro by swainsonine.

  2007cited by this paper
• New signals from the invasive front

  2006cited by this paper
• Pathology and molecular biology of gastric cancer.

  2006cited by this paper
• Terminal α1,4-linked N-acetylglucosamine in Helicobacter pylori-associated Intestinal Metaplasia of the Human Stomach and Gastric Carcinoma Cell Lines

  2006cited by this paper
• Glycan changes:cancer metastasis and anti-cancer vaccines

  2006cited by this paper
• Glycosylation in cellular mechanisms of health and disease.

  2006cited by this paper
• N-glycosylation of the beta-propeller domain of the integrin alpha5 subunit is essential for alpha5beta1 heterodimerization, expression on the cell surface, and its biological function.

  2006cited by this paper
• N-acetylglucosaminyltransferase III antagonizes the effect of N-acetylglucosaminyltransferase V on alpha3beta1 integrin-mediated cell migration.

  2006cited by this paper
• Terminal alpha1,4-linked N-acetylglucosamine in Helicobacter pylori-associated intestinal metaplasia of the human stomach and gastric carcinoma cell lines.

  2006cited by this paper
• N-Glycosylation Affects the Molecular Organization and Stability of E-cadherin Junctions*

  2006cited by this paper
• N-Acetylglucosaminyltransferase III Antagonizes the Effect of N-Acetylglucosaminyltransferase V on α3β1 Integrin-mediated Cell Migration*

  2006cited by this paper
• N-Glycosylation of the β-Propeller Domain of the Integrin α5 Subunit Is Essential for α5β1 Heterodimerization, Expression on the Cell Surface, and Its Biological Function*

  2006cited by this paper
• Genetics, Pathology, and Clinics of Familial Gastric Cancer

  2006cited by this paper
• Phase II study of the efficacy and safety of oral GD0039 in patients with locally advanced or metastatic renal cell carcinoma

  2005cited by this paper
• The sweet and sour of cancer: glycans as novel therapeutic targets

  2005cited by this paper
• Glycans in cancer and inflammation — potential for therapeutics and diagnostics

  2005cited by this paper
• Regulation of cadherin-mediated adhesion in morphogenesis

  2005cited by this paper
• Natural Antibiotic Function of a Human Gastric Mucin Against Helicobacter pylori Infection

  2004cited by this paper
• Functional Adaptation of BabA, the H. pylori ABO Blood Group Antigen Binding Adhesin

  2004cited by this paper
• Introduction of bisecting GlcNAc into integrin alpha5beta1 reduces ligand binding and down-regulates cell adhesion and cell migration.

  2004cited by this paper
• Role of the Human ST6GalNAc-I and ST6GalNAc-II in the Synthesis of the Cancer-Associated Sialyl-Tn Antigen

  2004cited by this paper
• Model of the early development of diffuse gastric cancer in E‐cadherin mutation carriers and its implications for patient screening

  2004cited by this paper

• Mimicking Gastric Cancer Collagen Reorganization with Decellularized ECM-Based Scaffolds

  2025cites this paper
• Harnessing technologies to unravel gastric cancer heterogeneity.

  2025cites this paper
• A novel glycogene-related signature for prognostic prediction and immune microenvironment assessment in kidney renal clear cell carcinoma

  2025cites this paper
• Branched Hierarchical Porous Carbon Enables Ultrasensitive Detection of Serum Glycans for Comprehensive Assessment of Urological Cancers

  2025cites this paper
• Proteomics Combined with N‑Glycoproteomics to Explore the Pathogenesis of Nasopharyngeal Carcinoma

  2025cites this paper
• Insights into E-Cadherin Impairment in CDH1-Unaltered Invasive Lobular Carcinoma: A Comprehensive Bioinformatic Study

  2024cites this paper
• Glycosylation: mechanisms, biological functions and clinical implications

  2024cites this paper
• Identification of serum N-glycans signatures in three major gastrointestinal cancers by high-throughput N-glycome profiling

  2024cites this paper
• Warning Signs From the Crypt: Aberrant Protein Glycosylation Marks Opportunities for Early Colorectal Cancer Detection

  2023cites this paper
• Glycosylated proteins with abnormal glycosylation changes are potential biomarkers for early diagnosis of breast cancer.

  2023cites this paper
• Prediction of gastric cancer by machine learning integrated with mass spectrometry-based N-glycomics.

  2023cites this paper
• Deep learning enhanced the diagnostic merit of serum glycome for multiple cancers

  2023cites this paper
• Robust Glycoproteomics Platform Reveals a Tetra‐Antennary Site‐Specific Glycan Capping with Sialyl‐Lewis Antigen for Early Detection of Gastric Cancer

  2023cites this paper
• Circulating Proteins as Diagnostic Markers in Gastric Cancer

  2023cites this paper
• Molecular basis for bacterial N-glycosylation by a soluble HMW1C-like N-glycosyltransferase

  2023cites this paper
• Key Roles of p53 Signaling Pathway-Related Factors GADD45B and SERPINE1 in the Occurrence and Development of Gastric Cancer

  2023cites this paper
• DNA nanoprobes for detection and imaging of glycoproteins

  2023cites this paper
• C-type lectin receptor Dectin-1 blockade on tumour-associated macrophages improves anti-PD-1 efficacy in gastric cancer

  2023cites this paper
• CircRNA ACVR2A Sponges miR-1290 to Modulate Cell Progression in Gastric Cancer

  2022cites this paper
• Lectin-Modified Magnetic Nano-PLGA for Photodynamic Therapy In Vivo

  2022cites this paper
• A novel glycosyltransferase-related lncRNA signature correlates with lung adenocarcinoma prognosis

  2022cites this paper
• p-Coumaric acid, Kaempferol, Astragalin and Tiliroside Influence the Expression of Glycoforms in AGS Gastric Cancer Cells

  2022cites this paper
• Glycans as shapers of tumour microenvironment: A sweet driver of T‐cell‐mediated anti‐tumour immune response

  2022cites this paper
• Salivary Glycopatterns as Potential Non-Invasive Biomarkers for Diagnosing and Reflecting Severity and Prognosis of Diabetic Nephropathy

  2022cites this paper
• Glycosyltransferases as targets for therapeutic intervention in cancer and inflammation: molecular modeling insights

  2022cites this paper
• Combined Action of Anti-MUC1 Monoclonal Antibody and Pyrazole-Platinum(II) Complexes Reveals Higher Effectiveness towards Apoptotic Response in Comparison with Monotherapy in AGS Gastric Cancer Cells

  2021cites this paper
• Mucin 1 as a Molecular Target of a Novel Diisoquinoline Derivative Combined with Anti-MUC1 Antibody in AGS Gastric Cancer Cells

  2021cites this paper
• Anti-Cancer Potential of Afzelin towards AGS Gastric Cancer Cells

  2021cites this paper
• Salivary protein glycopatterns for natural regulation of oral microbiota

  2021cites this paper
• Glioblastomas exploit truncated O-linked glycans for local and distant immune modulation via the macrophage galactose-type lectin

  2020cites this paper
• The Role of Glycans in Chronic Inflammatory Gastrointestinal and Liver Disorders and Cancer

  2020cites this paper
• Recombinant mucin-type proteins as tools for studies on the interactions between Helicobacter pylori and its carbohydrate receptors

  2020cites this paper
• Hereditary diffuse gastric cancer therapeutic roadmap: current and novel approaches in a nutshell

  2020cites this paper
• Impact of Gastrointestinal Symptoms in COVID-19: a Molecular Approach

  2020cites this paper
• hsa_circ_001653 up‐regulates NR6A1 expression and elicits gastric cancer progression by binding to microRNA‐377

  2020cites this paper
• A nomogram based on glycomic biomarkers in serum and clinicopathological characteristics for evaluating the risk of peritoneal metastasis in gastric cancer

  2020cites this paper
• Structural and Functional Insight Into the Glycosylation Impact Upon the HGF/c-Met Signaling Pathway

  2020cites this paper
• E‐cadherin deregulation in breast cancer

  2020cites this paper
• Esophageal, gastric and colorectal cancers: Looking beyond classical serological biomarkers towards glycoproteomics-assisted precision oncology

  2020cites this paper
• Ricin B-like lectin orthologues from two mushrooms, Hericium erinaceus and Stereum hirsutum, enable recognition of highly fucosylated N-glycans.

  2020cites this paper
• β-Catenin Protein and Its Association with Helicobacter Pylori as A Possible Marker for Gastric Cancer

  2019cites this paper
• Identification of abnormal fucosylated-glycans recognized by LTL in saliva of HBV-induced chronic hepatitis, cirrhosis, and hepatocellular carcinoma

  2019cites this paper
• O-glycans truncation modulates gastric cancer cell signaling and transcription leading to a more aggressive phenotype

  2019cites this paper
• Dynamic analysis of proteomic alterations in response to N‐linked glycosylation inhibition in a drug‐resistant ovarian carcinoma cell line

  2019cites this paper
• Non-invasive biomarkers for gastric cancer diagnosis: ready for prime time?

  2019cites this paper
• Exploring serum and immunoglobulin G N-glycome as diagnostic biomarkers for early detection of breast cancer in Ethiopian women

  2019cites this paper
• Functional roles of fucosylated and O-glycosylated cadherins during carcinogenesis and metastasis.

  2019cites this paper
• Translational glycobiology: from bench to bedside

  2019cites this paper
• protein glycosylation as a diagnostic and prognostic marker of chronic inflammatory gastrointestinal and liver diseases.

  2019cites this paper
• Carcinoembryonic antigen carrying SLeX as a new biomarker of more aggressive gastric carcinomas

  2019cites this paper
• Glycosylation in cancer: Selected roles in tumour progression, immune modulation and metastasis.

  2018cites this paper
• Clinicopathologic correlation with MUC expression in advanced gastric cancer

  2018cites this paper
• Identification of N - and O -linked glycans recognized by AAL in saliva of patients with atrophic gastritis and gastric cancer

  2018cites this paper
• Glycosylation of Cancer Stem Cells: Function in Stemness, Tumorigenesis, and Metastasis

  2018cites this paper
• Increased extracellular matrix density disrupts E-cadherin/β-catenin complex in gastric cancer cells.

  2018cites this paper
• Rosmarinic acid influences collagen, MMPs, TIMPs, glycosylation and MUC1 in CRL-1739 gastric cancer cell line.

  2018cites this paper
• The O-glycosylating enzyme GALNT2 suppresses the malignancy of gastric adenocarcinoma by reducing EGFR activities.

  2018cites this paper
• Alteration of glycosylation in serum proteins: a new potential indicator to distinguish non-diabetic renal diseases from diabetic nephropathy

  2018cites this paper
• A [Glyco]biomarker that Predicts Failure to Standard Therapy in Ulcerative Colitis Patients

  2018cites this paper
• Hericium erinaceus isolectins recognize mucin-type O-glycans as tumor-associated carbohydrate antigens on the surface of K562 human leukemia cells.

  2018cites this paper
• Development and Application of Proximity Assays for Proteome Analysis in Medicine

  2018influential citation
• Authenticus – List of Publications

  2018cites this paper
• The Double Face of Mucin-Type O-Glycans in Lectin-Mediated Infection and Immunity

  2018cites this paper
• Clinical and functional characterization of the CDH1 germline variant c.1679C>G in three unrelated families with hereditary diffuse gastric cancer

  2018cites this paper
• Pharmacological, Physiochemical, and Drug-Relevant Biological Properties of Short Chain Fatty Acid Hexosamine Analogues Used in Metabolic Glycoengineering.

  2017cites this paper
• Impact of abnormal Glycans expression in Cancer Immunoediting: Gastrointestinal Cancer as model

  2017influential citation
• Eucalyptus spp. outer bark extracts inhibit Helicobacter pylori growth: in vitro studies

  2017cites this paper
• Knockdown of ZFPL1 results in increased autophagy and autophagy‑related cell death in NCI‑N87 and BGC‑823 human gastric carcinoma cell lines.

  2017cites this paper
• Salivary glycopatterns as potential biomarkers for diagnosis of gastric cancer

  2017influential citation
• Characterization by Lectin Histochemistry of Two Subpopulations of Parietal Cells in the Rat Gastric Glands

  2017cites this paper
• Protein glycosylation in gastric and colorectal cancers: Toward cancer detection and targeted therapeutics.

  2017cites this paper
• Docosahexaenoic acid loaded lipid nanoparticles with bactericidal activity against Helicobacter pylori.

  2017cites this paper
• Discovery of Non-invasive Glycan Biomarkers for Detection and Surveillance of Gastric Cancer

  2017cites this paper
• Glycans as Regulatory Elements of the Insulin/IGF System: Impact in Cancer Progression

  2017cites this paper
• Polypeptide N-acetylgalactosaminyltransferase-6 expression in gastric cancer

  2017cites this paper
• Gastric Cancer Cell Glycosylation as a Modulator of the ErbB2 Oncogenic Receptor

  2017cites this paper
• MeCP2 regulated glycogenes contribute to proliferation and apoptosis of gastric cancer cells

  2017cites this paper
• Detection of post-translational modifications using solid-phase proximity ligation assay.

  2017cites this paper
• Plant Lectins as Medical Tools against Digestive System Cancers

  2017cites this paper
• Cadherins Glycans in Cancer: Sweet Players in a Bitter Process.

  2016cites this paper
• Progress of Glycomics in Breast Cancer

  2016cites this paper
• Host glycosylation pathways and the unfolded protein response contribute to the infection by Francisella

  2016cites this paper
• MUC1 Immunohistochemical Expression as a Prognostic Factor in Gastric Cancer: Meta-Analysis

  2016cites this paper
• Mechanisms of disease: The human N-glycome.

  2016cites this paper
• Hallmarks of glycosylation in cancer

  2016cites this paper
• Mucin-Type O-Glycosylation in Gastric Carcinogenesis

  2016cites this paper
• O-mannosylation and N-glycosylation: two coordinated mechanisms regulating the tumour suppressor functions of E-cadherin in cancer

  2016cites this paper
• Posttranslational Modifications: Key Players in Health and Disease

  2016cites this paper
• Short O-GalNAc glycans: regulation and role in tumor development and clinical perspectives.

  2016cites this paper
• N-linked glycosylation at Asn152 on CD147 affects protein folding and stability: promoting tumour metastasis in hepatocellular carcinoma

  2016cites this paper
• A Bitter Sweet Symphony: Immune Responses to Altered O-glycan Epitopes in Cancer

  2016cites this paper
• Preventing E-cadherin aberrant N-glycosylation at Asn-554 improves its critical function in gastric cancer

  2016cites this paper
• The promise of protein glycosylation for personalised medicine.

  2016cites this paper
• OXPHOS dysfunction regulates integrin-β1 modifications and enhances cell motility and migration.

  2015cites this paper
• Genetic Variations and Gastric Cancer Risk

  2015cites this paper
• Helicobacter pylori chronic infection and mucosal inflammation switches the human gastric glycosylation pathways.

  2015cites this paper
• Probing the O-Glycoproteome of Gastric Cancer Cell Lines for Biomarker Discovery*

  2015cites this paper
• Glycosylation in cancer: mechanisms and clinical implications

  2015cites this paper
• Comprehensive Glycomics of a Multistep Human Brain Tumor Model Reveals Specific Glycosylation Patterns Related to Malignancy

  2015cites this paper
• Exploring the role of O-Mannosylation in the modulation of E-Cadherin function in Gastric Cancer cell line models

  2015cites this paper